These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10071484)

  • 1. Coagulation protein function: the influence of acetaldehyde-modified heparin on thrombin activity.
    Brecher AS; Fu Q
    J Investig Med; 1999 Jan; 47(1):76-80. PubMed ID: 10071484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulation protein function VI: augmentation of anticoagulant function by acetaldehyde-treated heparin.
    Brecher AS; Hellman K; Basista MH
    Dig Dis Sci; 1999 Jul; 44(7):1349-55. PubMed ID: 10489917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of acetaldehyde-glycosaminoglycan mixtures upon Factor IXa and Factor IX-Deficient Plasma.
    Brecher AS; Moon AR; Gray KD
    Alcohol; 2006 Jun; 39(2):97-104. PubMed ID: 17134662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of S-hexyl-L-cysteine derivatives on prothrombin activation and clotting time determined in the presence of heparin.
    Midura-Nowaczek K; Bruzgo I; Krajewska D
    Adv Med Sci; 2009; 54(1):47-50. PubMed ID: 19648086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin chain-length dependence of factor Xa inhibition by antithrombin in plasma.
    Rezaie AR
    Thromb Res; 2007; 119(4):481-8. PubMed ID: 16515805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of glycosaminoglycans with acetaldehyde on the activation of prothrombin.
    Brecher AS; Adamu MT
    Can J Physiol Pharmacol; 2005 May; 83(5):431-8. PubMed ID: 15897925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetaldehyde inhibits chymotrypsin and serum anti-chymotrypsin activity.
    Brecher AS; Yang MP
    J Investig Med; 1998 Apr; 46(4):146-52. PubMed ID: 9635374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of thrombin in plasma by heparin or arginine.
    Stief TW
    Clin Appl Thromb Hemost; 2007 Apr; 13(2):146-53. PubMed ID: 17456623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of thrombin generation in whole blood--the effect of heparin and aspirin.
    Kessels H; Béguin S; Andree H; Hemker HC
    Thromb Haemost; 1994 Jul; 72(1):78-83. PubMed ID: 7974380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low molecular weight heparins prevent thrombin-induced thrombo-embolism in mice despite low anti-thrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition.
    Momi S; Nasimi M; Colucci M; Nenci GG; Gresele P
    Haematologica; 2001 Mar; 86(3):297-302. PubMed ID: 11255277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.
    Despotis GJ; Joist JH
    J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gabexate mesilate and heparin responsiveness in coronary patients.
    Ranucci M
    Med Sci Monit; 2004 Mar; 10(3):PI40-3. PubMed ID: 14976449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin-activated thrombelastography for evaluation of thrombin interaction with thrombin inhibitors.
    Taketomi T; Szlam F; Vinten-Johansen J; Levy JH; Tanaka KA
    Blood Coagul Fibrinolysis; 2007 Dec; 18(8):761-7. PubMed ID: 17982317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histidine-rich glycoprotein modulates the anticoagulant activity of heparin in human plasma.
    Lijnen HR; Van Hoef B; Collen D
    Thromb Haemost; 1984 Apr; 51(2):266-8. PubMed ID: 6740558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The monitoring of heparin administration by screening tests in experimental dogs.
    Mischke R; Jacobs C
    Res Vet Sci; 2001 Apr; 70(2):101-8. PubMed ID: 11356088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of acetaldehyde on human plasma factor XIII function.
    Suchocki EA; Brecher AS
    Dig Dis Sci; 2007 Dec; 52(12):3488-92. PubMed ID: 17436086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP; Bernat A; Gaich C; Herbert M
    Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of gentamicin on heparin activity.
    Tyler LS; Rehder TL; Davis RB
    Am J Hosp Pharm; 1981 Apr; 38(4):537-40. PubMed ID: 7282683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin clotting time.
    Ignjatovic V
    Methods Mol Biol; 2013; 992():131-8. PubMed ID: 23546710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.